Clonal genetic alterations in the lungs of current and former smokers

Journal of the National Cancer Institute

Volumn 89, Issue 12, 1997, Pages 857-862

  Mao, Li ^a,b   Lee, Jin Soo ^a   Kurie, Jonathan M ^a   Fan, You Hong ^a   Lippman, Scott M ^a   Lee, J Jack ^a   Ro, Jae Y ^a   Broxson, Anita ^a   Yu, Ren ^a   Morice, Rodolfo C ^a   Kemp, Bonnie L ^a   Khuri, Fadlo R ^a   Walsh, Garrett L ^a   Hittelman, Walter N ^a   Hong, Waun Ki ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 9P; FEMALE; GENE LOCATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SMOKING; TUMOR SUPPRESSOR GENE;

EID: 1842298166     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.12.857     Document Type: Article

References (33)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46: 5-27.
2. Garfinkel L, Silverberg E. Lung cancer and smoking trends in the United States over the past 25 years. CA Cancer J Clin 1991;41:137-45.
3. Kessler DA, Witt AM, Barnett PS, Zeller MR, Natanblut SL, Wilkenfeld JP, et al. The Food and Drug Administration's regulation of tobacco products. N Engl J Med 1996;335:988-94.
4. Strauss GM, Gleason R, Sugarbaker DJ. Screening for lung cancer - re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening. Chest 1993;103(4 Suppl):3375-415.
5. Tong L, Spitz MR, Fueger JJ, Amos CA. Lung carcinoma in former smokers. Cancer 1996;78: 1004-10.
6. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961;265:253-67.
7. Auerbach O, Gere JB, Forman JB, Petrick TG, Smolin HJ, Muehsam GE, et al. Changes in bronchial epithelium in relation to smoking and cancer of the lung: a report of progress. N Engl J Med 1957;256:97-104.
8. Hunter T. Cooperation between oncogenes. Cell 1991;64:249-70.
9. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alteration during colorectal tumor development. N Engl J Med 1988;319:525-32.
10. Knudson AG Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-43.
11. Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 1995;87:1224-9.
12. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma [published erratum appears in JAMA 1995; 273:1908]. JAMA 1995;273:558-63.
13. Thiberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvet G, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995;55:5133-9.
14. Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM. et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994;12:937-45.
15. Woolson RF. Statistical methods for the analyses of biomedical data. New York: Wiley and Sons Inc., 1987.
16. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
17. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
18. Nobori T, Muira K, Wu D, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
19. Mooney LA, Santella RM, Covey L, Jeffrey AM, Bigbee W, Randall MC, et al. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev 1995;4:627-34.
20. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996;2:682-5.
21. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
22. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localisation of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320:84-5.
23. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992; 7:1989-97.
24. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:712-7.
25. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 1996;274:430-2.
26. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai K, et al. p53 mutations in lung cancers from non-smoking atomic-bomb survivors [published erratum appears in Lancet 1994;343:1302]. Lancet 1993; 342:1520-1.
27. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993;85: 457-64.
28. Lubin JH, Blot WJ. Lung cancer and smoking cessation: patterns of risk [editorial]. J Natl Cancer Inst 1993;85:422-3.
29. Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-P1,P3-triphosphate hydrolase. Biochemistry 1996;35:11529-35.
30. Grummt F. Diadenosine 5′,5‴-P1,P4-tetraphosphate triggers initiation of in vitro DNA replication in baby hamster kidney cells. Proc Natl Acad Sci USA 1978;75:371-5.
31. Weinmann-Dorsch C, Hedl A, Grummt I, Albert W, Ferdinand FJ, Friis RR, et al. Drastic rise of intracellular adenosine(5′)tetraphospho(5′)adenosine correlates with onset of DNA synthesis in eukaryotic cells. Eur J Biochem 1984;138:179-85.
32. Weinmann-Dorsch C, Grummt F. High diadenosine tetraphosphate (Ap4A) level in germ cells and embryos of sea urchin and Xenopus and its effect on DNA synthesis. Exp Cell Res 1985;160:47-53.
33. Grummt F, Weinmann-Dorsch C, Schneider-Schaulies J, Lux A. Zinc as a second messenger of mitogenic induction. Effects on diadenosine tetraphosphate (Ap4A) and DNA synthesis. Exp Cell Res 1986;163:191-200.